Clinical Trial Update: A Pilot Study of Neurocysticercosis Treatment [Phase 3]

View source ↗

Summary

Phase 3 pilot study evaluating treatment for neurocysticercosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neurocysticercosis

Snippet

Sponsor: Columbia University | Conditions: Neurocysticercosis | Phase 3 | Status: COMPLETED